Asian markets were mixed on Monday as concerns over trade tensions moved to the forefront at the meeting this weekend of the Group of 20 industrial nations.
Harsh drought conditions in parts of the American West are pushing wild horses to the brink and spurring extreme measures to protect them.
China has launched a trade investigation of steel from Europe and South Korea, potentially complicating efforts to recruit them as allies in its tariff dispute with U.S. President Donald Trump.
China's No. 2 leader has ordered an investigation of its vaccine industry after violations by a maker of rabies vaccine for humans prompted a public outcry.
Ride-sharing company Uber has suspended a driver who recorded hundreds of St. Louis-area riders without their permission and streamed the live video online.
Hint: It's not a small number.
Which off-price retailer should you be eyeing?
Geron Corporation and Viking Therapeutics are both racing toward key clinical catalysts that could cause their shares to skyrocket.
And will it matter in the long run?
The European financial affairs commissioner says that differences of position on trade remain despite talks between G-20 officials meeting in Argentina's capital.
You have every right to be ticked off at the way Congress has handled Social Security's imminent problems.
The e-commerce giant's stock has had a massive run so far this year. Will its financial results propel it to even greater heights or send it crashing down?
Not all advisors are created equal. Here's how to know when you ought to let yours go.
Syntel is a 38-year-old information technology company with 23,000 employees.
After a rough start to the year, which ubiquitous eatery is the right fit for your portfolio?
These are the three big trends investors will be following.
Find out why these five restaurant stocks have taken a beating in 2018.
Mondelez Global says it's voluntarily recalling some of its Ritz Cracker products over potential risk of salmonella.
These are one Fool's three highest-conviction high-yield investment opportunities.
This marijuana stock looks dirt cheap based on one popular valuation metric. But appearances can be deceiving.